Weight-loss drugs may lower risk of obesity-related cancers

Popular GLP-1 weight-loss drugs like Ozempic and Zepbound can help reduce a woman’s risk for as many as 14 cancers associated with obesity, a new study says.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup